TAN1 Antibody

What is the TAN1 protein and what role does it play in plant cellular processes?

TAN1 (Tangled1) is a highly basic microtubule-binding protein (pI of 12.6) with a predicted molecular mass of 41 kD that plays a crucial role in the spatial control of cytokinesis during maize leaf development. The protein participates in the orientation of cytoskeletal structures in dividing cells through its association with microtubules (MTs). Specifically, TAN1 is required for proper guidance of the cytokinetic apparatus (phragmoplast) to the cortical "division site" established before mitosis .

In tan1 mutants, cytoskeletal structures involved in establishing planes of cell division (preprophase bands or PPBs) and forming new cell walls (phragmoplasts) appear structurally normal but are frequently misoriented, leading to abnormal cell division patterns. The TAN1 protein shows distant similarity to the basic regions of vertebrate APC proteins, which are known to bind tubulin and associate with MTs .

What types of antibodies against TAN1 have been developed and characterized?

Several types of antibodies targeting different epitopes of TAN1 have been successfully developed and characterized:

• Polyclonal rabbit antibodies raised against a COOH-terminal TAN1 peptide (CGLKQRPGYSLTVRTVSSKISSR) coupled to keyhole limpet hemocyanin, which were subsequently affinity-purified on peptide-coupled SulfoLink beads

• Monoclonal antibodies (mAbs) raised against the NH2-terminal portion of TAN1 encoded by exons 1 and 2, expressed as a glutathione S-transferase (GST) fusion protein and cleaved from GST with thrombin protease. One specific mAb from this approach, designated TAN75, has been extensively characterized

• Additional polyclonal antibodies raised against other fragments of TAN1 covering its entire length

These antibodies have been validated through Western blotting, immunolocalization, and peptide competition experiments, confirming their specificity for TAN1 while noting potential cross-reactivity with TAN1-related proteins.

How is the TAN1 gene expressed in plant tissues and what does this tell us about its function?

The TAN1 gene expression pattern strongly correlates with cell division activity, providing important insights into its biological function:

• Northern blot analysis reveals a single mRNA of approximately 1.5 kb in wild-type vegetative shoot tips enriched in actively dividing cells

• TAN1 mRNA is vastly reduced in shoot segments composed of postmitotic expanding leaf cells, differentiating leaf cells, and mature leaf tissue

• Strong expression is observed in other tissues enriched in dividing cells, including ear primordia and embryos

• TAN1 mRNA levels are greatly reduced in tan1-Mu1 mutants and to a lesser extent in tan1-py1 mutants, while only slightly reduced in tan-gt1 mutants (consistent with the presence of a premature stop codon in this allele)

This expression pattern confirms that TAN1 function is primarily associated with actively dividing cells rather than expanding or differentiated cells, supporting its role in the spatial control of cytokinesis during plant development.

What are the optimal protocols for immunolocalization studies using TAN1 antibodies?

For effective immunolocalization studies with TAN1 antibodies, researchers should follow these methodological guidelines:

Sample preparation:

• Select tissues with active cell division (e.g., shoot tips, ear primordia) where TAN1 is abundantly expressed

• Use appropriate fixation protocols to preserve antigen recognition while maintaining cellular structure

Antibody application:

• Both monoclonal (e.g., TAN75) and polyclonal (COOH-terminal peptide) antibodies can be effectively used for cell labeling

• Include appropriate controls:

  • Peptide competition experiments (pre-incubation of antibody with specific peptide should abolish labeling)

  • Wild-type versus mutant tissue comparisons

  • Secondary antibody-only controls to assess background

Double-labeling approach:

• Co-label with anti-β-tubulin antibodies to confirm association with microtubule structures

• This allows visualization of the coincidence of TAN1 labeling with PPB, spindle, and phragmoplast structures

Analysis considerations:

• Examine cells at different cell cycle stages to observe the dynamic localization patterns:

  • In interphase: uniform cytoplasmic distribution excluded from the nucleus

  • In mitotic cells: preferential association with PPB, spindle, and phragmoplast

• Document the punctate labeling pattern characteristic of TAN1 antibodies

How can microtubule overlay assays be optimized to study TAN1's interaction with microtubules?

The microtubule overlay assay provides direct evidence of TAN1's ability to bind MTs. For optimal results, follow this methodological approach:

Protein preparation options:

• Recombinant protein approach:

  • Express His-tagged TAN1 protein in E. coli

  • Confirm expression via SDS-PAGE with Coomassie blue staining

• Native protein approach:

  • Prepare extracts from maize vegetative shoot tips where TAN1 is expressed

  • Include appropriate controls (e.g., extracts from tan1 mutants)

Overlay assay procedure:

• Separate proteins via SDS-PAGE

• Transfer proteins to membranes

• Block membranes following standard protocols

• Prepare parallel membranes - one for incubation with polymerized MTs, one without (control)

• Incubate with MTs polymerized from purified tubulin (e.g., bovine brain tubulin)

• Detect bound MTs using anti-β-tubulin antibody

• For plant extracts, account for detection of endogenous tubulin with or without prior MT incubation

Results interpretation:

• In E. coli extracts: MTs should bind specifically to the His-tagged TAN1 protein

• In plant extracts: Anti-β-tubulin will detect both endogenous tubulin and MTs bound to the 43-kD TAN1 protein

• Compare wild-type and mutant extracts to confirm specificity

This assay conclusively demonstrates that TAN1 protein can directly bind to MTs, supporting its proposed function in orienting cytoskeletal structures during cell division.

What Western blot analysis approaches are most effective for detecting TAN1 protein?

For optimal Western blot detection of TAN1 protein, consider the following comprehensive protocol:

Sample preparation:

• Extract proteins from tissues with active cell division (vegetative shoot tips, ear primordia, embryos)

• Consider subcellular fractionation:

  • Sequential centrifugation at increasing speeds (3,000-15,000 g)

  • The majority of TAN1 sediments at 6,000-9,000 g

• Include appropriate controls:

  • Wild-type tissue extracts

  • tan1 mutant extracts (reduced signal expected)

  • Expanding or differentiating tissue extracts (minimal signal expected)

Electrophoresis and transfer:

• Separate proteins via SDS-PAGE (standard conditions)

• Transfer to appropriate membrane (typically PVDF or nitrocellulose)

Antibody detection:

• Primary antibody options:

  • Affinity-purified COOH-terminal peptide antibody

  • Monoclonal antibody TAN75

• Both antibodies predominantly recognize a single protein band at approximately 43 kD, close to the predicted TAN1 molecular mass of 41 kD

Expected results and interpretation:

• Wild-type extracts should show a prominent 43 kD band

• Mutant extracts will show reduced intensity of this band

• The 43 kD protein is not detected in extracts from expanding or differentiating leaf tissue

• Be aware that anti-TAN1 antibodies may recognize TAN1-related proteins in addition to TAN1 itself, especially in mutant backgrounds

How do TAN1-related proteins complicate antibody-based studies, and what strategies can address this challenge?

The existence of TAN1-related proteins presents significant challenges for antibody-based studies. The evidence and recommended strategies include:

Evidence for TAN1-related proteins:

• Western blot analysis shows reduced but not eliminated detection of a 43 kD protein in tan1 mutants

• The truncated form of TAN1 protein encoded by the tan-gt1 allele would not be recognized by the COOH-terminal peptide antibody and would not comigrate with full-length TAN1, suggesting the detected protein is from another gene

• Multiple antibodies raised against non-overlapping regions of TAN1 recognize similar proteins in mutant backgrounds

• Genomic analysis identified a DNA fragment that hybridizes with the TAN1 probe at low but not high stringency, potentially corresponding to a gene 80-90% identical to TAN1

Strategies to address this challenge:

Researchers studying TAN1 should combine multiple approaches and carefully interpret results with awareness of potential cross-reactivity with TAN1-related proteins .

What is the relationship between TAN1's microtubule binding activity and its potential role in orienting cytoskeletal structures?

The relationship between TAN1's microtubule binding activity and its role in cytoskeletal orientation is complex and illuminates its cellular function:

Key experimental observations:

• TAN1 is a highly basic protein (pI of 12.6) with distant similarity to the basic regions of vertebrate APC proteins, which are known to bind tubulin

• Both recombinant and native TAN1 protein directly bind to MTs in overlay assays

• Proteins recognized by anti-TAN1 antibodies preferentially associate with MT-containing cytoskeletal structures (PPBs, spindles, and phragmoplasts)

• This association appears to be cell cycle-dependent, occurring primarily in dividing cells

• In tan1 mutants, cytoskeletal structures appear structurally normal but are frequently misoriented

Functional model:
TAN1 likely functions as a molecular bridge between MTs and other cellular components required for proper orientation of cytoskeletal structures. The protein may mediate interactions between these structures and the cell cortex necessary for their proper orientation, such as guiding phragmoplasts to cortical division sites previously occupied by PPBs .

The MT-binding capability appears essential for this function, while the cell cycle-dependent association suggests regulatory mechanisms that control when and where TAN1 interacts with the cytoskeleton. This model explains why in tan1 mutants, cytoskeletal structures form normally but fail to orient properly—the structural components remain intact, but the guidance mechanism is compromised .

How might post-translational modifications regulate TAN1's interaction with the cytoskeleton?

While direct evidence of post-translational modifications (PTMs) affecting TAN1 is not presented in the available data, several observations suggest potential regulatory mechanisms:

Observations suggesting regulated interaction:

• Cell cycle-dependent association: Proteins recognized by anti-TAN1 antibodies associate with MT structures primarily during cell division, not during interphase

• Differential subcellular localization: In interphase cells, TAN1 is distributed throughout the cytoplasm; in mitotic cells, it preferentially associates with cytoskeletal structures

• Physical properties: TAN1 sediments at 6,000-9,000 g in centrifugation experiments, suggesting association with large or dense structures

Potential regulatory mechanisms:

Future research could employ these approaches to elucidate the specific mechanisms regulating TAN1's dynamic association with cytoskeletal structures during the cell cycle, providing deeper insight into its role in orienting the division machinery during plant cell cytokinesis .

What are common challenges in detecting TAN1 protein in plant tissues and how can they be overcome?

Researchers working with TAN1 antibodies may encounter several challenges. The following table summarizes these challenges and provides practical solutions:

For optimal detection, researchers should:

• Process samples quickly to minimize protein degradation

• Consider enrichment strategies to concentrate TAN1-containing fractions

• Include appropriate positive and negative controls in every experiment

• Validate findings using multiple detection methods when possible

What controls are essential when using TAN1 antibodies for experimental applications?

When working with TAN1 antibodies, a comprehensive set of controls ensures reliable and interpretable results:

Essential controls for immunolocalization:

• Peptide competition: Pre-incubation of the antibody with COOH-terminal TAN1 peptide-coupled beads should reduce labeling to background levels, while pre-incubation with beads coupled to an unrelated peptide should have no effect

• Wild-type vs. mutant comparison: Compare labeling patterns in wild-type tissues versus tan1 mutant tissues (expect reduced but not eliminated signal in mutants)

• Cell cycle stage documentation: Examine and document cells at different cell cycle stages to confirm cell cycle-dependent patterns of localization

• Double labeling: Co-label with anti-β-tubulin antibodies to confirm association with microtubule structures (PPB, spindle, phragmoplast)

Essential controls for Western blotting:

• Positive control: Include extract from tissues known to express TAN1 (e.g., vegetative shoot tips)

• Negative control: Include extract from tissues with minimal TAN1 expression (e.g., mature leaf tissue)

• Mutant comparison: Include extracts from tan1 mutant tissues to assess band intensity reduction

• Multiple antibodies: Compare results using antibodies raised against different regions of TAN1

Essential controls for MT overlay assays:

• No-MT incubation control: Prepare duplicate membranes - one incubated with MTs, one without

• Recombinant protein control: Include purified recombinant TAN1 as a positive control

• Unrelated protein control: Include proteins not expected to bind MTs

These controls help ensure the specificity and reliability of results when working with TAN1 antibodies, particularly given the challenges of distinguishing between TAN1 and related proteins.

How can researchers validate that the proteins detected by TAN1 antibodies are indeed TAN1 and not related proteins?

Distinguishing between TAN1 and TAN1-related proteins requires a multi-faceted approach:

Genetic approaches:

• Compare protein detection in wild-type plants versus plants carrying defined tan1 mutant alleles

• The expression pattern should correlate with known TAN1 gene expression

• In tan-gt1 mutants, the truncated form of TAN1 protein would not be recognized by the COOH-terminal peptide antibody and would not comigrate with full-length TAN1

Molecular approaches:

• Design antibodies against regions unique to TAN1 rather than conserved regions shared with related proteins

• Use high-stringency hybridization or specific PCR primers to distinguish between TAN1 and related genes at the nucleic acid level

• Consider RNA interference or CRISPR-based approaches to specifically reduce TAN1 expression and monitor antibody reactivity

Biochemical approaches:

• Immunoprecipitate proteins recognized by anti-TAN1 antibodies followed by mass spectrometry for definitive identification

• Compare migration patterns on 2D gels to separate proteins of similar molecular weight but different isoelectric points

• Exploit the highly basic nature of TAN1 (pI 12.6) for separation from less basic related proteins

Functional approaches:

• Assess whether proteins detected by TAN1 antibodies share TAN1's microtubule binding capability

• Examine whether the detected proteins show the same cell cycle-dependent association with cytoskeletal structures

• Determine if the detected proteins complement tan1 mutant phenotypes when expressed transgenically

By combining multiple validation approaches, researchers can increase confidence that the proteins detected by their antibodies are indeed TAN1 or can appropriately distinguish between TAN1 and related proteins.

What approaches could identify TAN1-interacting proteins that may regulate its association with the cytoskeleton?

Identifying TAN1-interacting proteins would provide crucial insights into its regulation and function. Several complementary approaches could be employed:

Biochemical approaches:

• Co-immunoprecipitation using anti-TAN1 antibodies followed by mass spectrometry

• GST pull-down assays using recombinant TAN1 as bait

• Cross-linking followed by immunoprecipitation to capture transient interactions

• Proximity labeling methods (BioID, APEX) to identify proteins in close proximity to TAN1 in vivo

Genetic approaches:

• Yeast two-hybrid screening using TAN1 as bait

• Suppressor/enhancer screens to identify mutations that modify tan1 mutant phenotypes

• Synthetic lethal screens to identify genes functionally related to TAN1

Cell biological approaches:

• Fluorescence resonance energy transfer (FRET) to detect direct protein-protein interactions in vivo

• Co-localization studies combining TAN1 antibodies with antibodies against candidate interacting proteins

• Live-cell imaging with fluorescently tagged proteins to monitor dynamic interactions

Potential TAN1-interacting proteins might include:

• Proteins associated with the cell cortex that could anchor microtubule structures

• Cell cycle regulators that could control TAN1's association with the cytoskeleton

• Proteins involved in microtubule dynamics or organization

• Components of the division site memory mechanism that maintains positional information between PPB formation and phragmoplast guidance

How might comparative studies between TAN1 and related proteins advance our understanding of cytoskeletal regulation during plant cell division?

Comparative studies between TAN1 and related proteins could provide valuable insights into cytoskeletal regulation mechanisms:

Sequence and structural comparisons:

• Identify conserved domains that might be essential for microtubule binding or other functions

• Determine unique regions that might confer specific functions to TAN1 versus related proteins

• Analyze evolutionary relationships to understand the diversification of this protein family

Functional comparisons:

• Assess whether TAN1-related proteins can bind microtubules in overlay assays

• Compare cellular localization patterns throughout the cell cycle

• Determine if related proteins associate with the same cytoskeletal structures as TAN1

• Evaluate functional redundancy through genetic studies

Expression pattern comparisons:

• Examine whether related genes show the same correlation with cell division as TAN1

• Investigate potential differential expression across tissues or developmental stages

• Assess whether related genes are regulated by similar transcriptional mechanisms

Mutant phenotype comparisons:

• Generate and characterize mutations in TAN1-related genes

• Create double/triple mutants to assess genetic interactions

• Determine if related proteins can compensate for loss of TAN1 function

These comparative approaches could reveal:

• The degree of functional redundancy within this protein family

• Specialized roles for different family members in cytoskeletal regulation

• Evolutionary conservation of mechanisms controlling cytoskeletal orientation during cell division

• Potential for developing more specific tools to study individual family members

What experimental approaches could elucidate the molecular mechanisms by which TAN1 contributes to division plane orientation?

Understanding the precise molecular mechanisms by which TAN1 orients the division plane requires sophisticated experimental approaches:

Structural biology approaches:

• Determine the three-dimensional structure of TAN1, particularly its microtubule-binding domain

• Map the regions of TAN1 required for its various functions through deletion analysis

• Identify specific amino acids critical for microtubule binding through site-directed mutagenesis

Live-cell imaging approaches:

• Generate functional fluorescently-tagged TAN1 constructs for in vivo studies

• Track TAN1 dynamics during the cell cycle using time-lapse microscopy

• Visualize TAN1's relationship with cytoskeletal structures in real time

• Employ photobleaching techniques (FRAP, FLIP) to assess TAN1 mobility and turnover

Biochemical characterization:

• Determine TAN1's effects on microtubule dynamics in vitro (polymerization, stabilization)

• Assess whether TAN1 can bundle or cross-link microtubules

• Identify post-translational modifications that regulate TAN1 activity

• Characterize the binding affinity and kinetics of TAN1-microtubule interactions

Advanced genetic approaches:

• Create separation-of-function mutations that affect specific aspects of TAN1 function

• Develop inducible systems to manipulate TAN1 expression or activity at specific cell cycle stages

• Use genome editing to introduce tagged versions of TAN1 at the endogenous locus

Based on current knowledge, a working model suggests that TAN1 might function as a molecular bridge between microtubules and the cell cortex, particularly at the division site, helping to guide the phragmoplast to the cortical division site previously occupied by the PPB. Future research using these approaches will help refine this model and elucidate the specific molecular mechanisms involved .